Telotristat ethyl in carcinoid syndrome: safety and efficacy in the TELECAST phase 3 trial.
about
Telotristat ethyl in carcinoid syndrome: safety and efficacy in the TELECAST phase 3 trial.
description
2018 nî lūn-bûn
@nan
2018年の論文
@ja
2018年学术文章
@wuu
2018年学术文章
@zh
2018年学术文章
@zh-cn
2018年学术文章
@zh-hans
2018年学术文章
@zh-my
2018年学术文章
@zh-sg
2018年學術文章
@yue
2018年學術文章
@zh-hant
name
Telotristat ethyl in carcinoid ...... in the TELECAST phase 3 trial.
@en
Telotristat ethyl in carcinoid ...... in the TELECAST phase 3 trial.
@nl
type
label
Telotristat ethyl in carcinoid ...... in the TELECAST phase 3 trial.
@en
Telotristat ethyl in carcinoid ...... in the TELECAST phase 3 trial.
@nl
prefLabel
Telotristat ethyl in carcinoid ...... in the TELECAST phase 3 trial.
@en
Telotristat ethyl in carcinoid ...... in the TELECAST phase 3 trial.
@nl
P2093
P2860
P356
P1476
Telotristat ethyl in carcinoid ...... in the TELECAST phase 3 trial.
@en
P2093
David J Gross
Dieter Hörsch
Douglas Fleming
Kenneth Kassler-Taub
Lowell B Anthony
Marianne Pavel
Marta Benavent
Martin O Weickert
Matthew H Kulke
Pablo Lapuerta
P2860
P304
P356
10.1530/ERC-17-0455
P577
2018-01-12T00:00:00Z